AAIC Submission Site

Welcome

NOTE: This site works best in Internet Explorer.

Thank you for your interest in submitting an abstract to the Alzheimer's Association International Conference (AAIC), July 13-18, 2013 in Boston, Massachusetts, United States.

Top dementia researchers from around the world have submitted innovative, exciting information for AAIC 2013. But if you are still at work on your latest discovery, there is one more chance to present at this year’s conference. If you have late-breaking, up-to-the-minute research, Developing Topics is the place to share it for the first time. AAIC will accept new abstracts for both oral and poster sessions from April 22–May 6. *Featured Research Sessions are not accepted for Developing Topics.

Topics of interest include basic translational science, diagnosis and prognosis, therapeutics, public health and psychosocial.

Criteria for application:

Quality of scientific research
Relevance to Alzheimer’s disease and related disorders
Late-breaking research/newness of information
Potential impact on the research community
Previously submitted/reviewed abstracts will not be considered.

The Developing Topics abstract submission process is open from Monday, April 22 – Monday, May 6, 2013 11:59 p.m. Central Standard Time.

For the submitted program of AAIC, an individual may be the presenting author on one oral presentation (oral platform or featured research session) and two posters slotted on different days. All presenting authors must register and pay for the conference in order to present. Registration is open (www.alz.org/aaic).

Questions & Support:
Topic	Email	Phone
General AAIC and Abstract Questions	AAICSpeakers@alz.org	+1-312-335-5897 (between 9am - 5pm Central Time, Monday-Friday)
Technical Support (log in issues, technical entry issues)	multiviewmediasupport@multiview.com	+1-289-695-5400 (between 9am - 5pm Eastern Time, Monday-Friday)
Please consult Dates/Frequently Asked Questions section prior ro contacting the Association or Technical Support. many of your questions will be answered in this sections.

Embargo Reminder: All materials submitted to AAIC that are chosen to be part of the Alzheimer’s Association news program for AAIC are embargoed for publication and broadcast until the officially scheduled date and time of presentation at the conference, unless the Alzheimer's Association provides written notice of change of date and/or time in advance (See full policy below).

Full News Embargo
The Alzheimer’s Association International Conference (AAIC) is a well-recognized, global platform for news regarding advances in Alzheimer’s and dementia research. If you are interested in having the research you present at AAIC eligible for inclusion in AAIC news releases and news conferences, it must not be published (online or hard copy) or presented previous to presentation at AAIC. The Association reserves the right to include previously published material in its news program, if it so chooses.

All materials submitted to AAIC that are chosen to be part of the Alzheimer’s Association news program for AAIC are embargoed for publication and broadcast until the officially scheduled date and time of presentation at the conference, unless the Alzheimer's Association provides written notice of change of date and/or time in advance.

Embargo is the prohibition for copyright reasons from releasing any content from an accepted abstract to the public until after it has been presented at AAIC. Prior to presentation at AAIC, authors may not release information to the news media or the public, nor publish the results in any manner, and must ensure that colleagues and other organizations or institutions are aware of this policy. Violation of the embargo may include retraction of the accepted abstract and/or loss of privileges of presenting research at AAIC in the future.

All news media representatives, scientists and their funders, and exhibitors/sponsors agree to honor the embargoes and release times stated on news releases and other news materials issued by the Alzheimer's Association/AAIC 2013. If a reporter or news media outlet breaks an AAIC 2013 news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events. If a scientist or company that is a participant in an AAIC 2013 news briefing or news release is discovered to have broken the news embargo, or encouraged the breaking of a news embargo, the Alzheimer’s Association reserves the right to remove the participant from the news briefing and remove that scientist’s/company’s information from the news release.